Stratifying HR+ HER2- breast cancer through ER signaling and G2/M molecular signatures

Molecular signatures improve patient stratification beyond standard IHC clinical markers

INDICATION

Breast

BIOMARKER

ER Signaling

Related cases

Grid of orange, blue, purple, and green square blocks with scattered black dots.

Mutational profiles and treatment resistance in metastatic TNBC

Abstract grid of purple dots forming a diagonal pattern and a vertical line.

Impact of PIK3R1 loss-of-function on survival in metastatic breast cancer

Data visualization showing two dot plot distributions, one blue and one pink, on a white grid.

Molecular and clinical characterization of HER2-low versus HER2-0 breast cancer